The varicella (chickenpox) vaccine provides strong protection for at least 20 years, and likely longer. Research has confirmed that immune cells capable of fighting the virus persist in both blood and bone marrow for more than two decades after childhood vaccination. No booster dose is currently recommended for healthy people who completed the standard two-dose series.
How Long Protection Actually Lasts
The two-dose varicella vaccine series is 98% effective at preventing any form of chickenpox in clinical trials, and 100% effective against severe disease. Real-world studies put the effectiveness slightly lower, around 92% (ranging from 88% to 98%), which is still remarkably high for a vaccine.
The key question most people have is whether that protection fades. A study published in the Journal of Virology tracked vaccinated individuals and found that specialized immune cells targeting the varicella-zoster virus were still present in bone marrow and blood up to two decades after vaccination. These cells, a type of memory T cell, are what your body relies on to recognize and fight the virus if you’re ever exposed. Their persistence suggests the vaccine creates durable, long-lasting immunity rather than short-term protection that wears off.
Antibody levels in your blood can decline over time, which sometimes raises concern. But antibodies are only one layer of defense. The memory T cells act as a backup, ready to trigger a rapid immune response even when circulating antibody levels are low. This is why vaccinated people remain well-protected years later, even if a blood test doesn’t show high antibody numbers.
One Dose vs. Two Doses
The difference between one and two doses is significant. A single dose is 82% effective at preventing any chickenpox and almost 100% effective against severe cases. Two doses push protection to 98% against any infection and 100% against severe disease. That second dose closes the gap substantially, which is why the CDC recommends two doses for children, adolescents, and adults who lack evidence of immunity.
If you only received one dose as a child (common for people vaccinated before 2006, when the two-dose schedule was adopted), getting a second dose is worthwhile. There’s no maximum time limit between the first and second dose, so a catch-up shot works even years later.
Breakthrough Infections in Vaccinated People
A small percentage of vaccinated people can still catch chickenpox, known as a breakthrough infection. These cases look and feel very different from chickenpox in an unvaccinated person. Breakthrough infections typically involve fewer than 50 skin lesions, little or no fever, and a shorter illness. The rash itself often doesn’t look like classic chickenpox blisters. Instead, the spots tend to be flat and atypical rather than fluid-filled, which can actually make them harder to identify as chickenpox at all.
This mildness is itself evidence that the vaccine is working. Even when the virus slips past your immune defenses enough to cause symptoms, your body’s trained response keeps the infection from becoming severe.
Do You Need a Booster?
Currently, no booster is recommended after completing the two-dose series. The CDC considers documentation of two age-appropriate doses sufficient evidence of immunity. Unlike some vaccines that require periodic boosters throughout adulthood, the varicella vaccine appears to maintain its protective effect without additional doses.
This applies whether you received the standalone varicella vaccine or the combination MMRV vaccine (which also covers measles, mumps, and rubella). Both provide the same level of protection against chickenpox.
Can You Test Your Immunity?
You might assume a blood test could tell you whether you’re still protected, but it’s not that simple. Standard commercial antibody tests for varicella are not sensitive enough to reliably detect vaccine-induced immunity. These tests work reasonably well for people who had natural chickenpox, since a wild infection generates higher antibody levels, but they frequently miss the immune response created by vaccination. A negative result on one of these tests doesn’t necessarily mean you’re unprotected.
The CDC specifically notes that routine immunity testing after vaccination is unnecessary for this reason. If you have documentation of two doses, that’s considered reliable evidence of immunity regardless of what a blood test might show.
Varicella Vaccine and Shingles Risk
The varicella-zoster virus is the same virus that causes shingles later in life. After a natural chickenpox infection, the virus hides in nerve tissue and can reactivate decades later. Vaccinated people can also develop shingles, but their risk is lower than those who had natural chickenpox. The memory T cells generated by the vaccine play a role in keeping the virus dormant, though this cellular immunity can weaken with age. In older adults, declining T cell numbers are associated with increased risk of reactivation, which is why a separate shingles vaccine exists for people over 50.